Celgene Corporation is an integrated biopharmaceutical company. The Company is primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory-related diseases. The Company’s lead product is REVLIMID (lenalidomide) and... more

Array BioPharma Inc. (Array) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs. The Company’s drug development pipeline includes clinical candidates that are designed to treat patients afflicted with cancer,... more

Albany Molecular Research, Inc. provides scientific services, technologies and products. The Company's core business consists of a fee-for-service contract services platform encompassing drug discovery, development and manufacturing, and a separate, stand-alone research and development... more

ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company’s lead products, which are in clinical-stage testing, consist of ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase; ARQ 501, an... more

Emisphere Technologies, Inc. (Emisphere) is a biopharmaceutical company that focuses on delivery of therapeutic molecules using its eligen technology. The eligen technology can be applied to the oral route of administration, as well other delivery pathways, such as buccal, rectal,... more

OXIS International, Inc. (OXIS) focuses on the research and development of technologies and therapeutic products in the field of oxidative stress/inflammatory reaction, diseases that are associated with damage from free radicals and reactive oxygen species. Its products include... more

CombiMatrix Corporation, formerly Acacia Research-CombiMatrix, is a biotechnology company, with a subsidiary, CombiMatrix Molecular Diagnostics, Inc. (CMDX). CombiMatrix's electrochemical manufacturing process utilizes standard semiconductor technology, software and chemistry to build... more

ChemCodes has developed a proprietary high throughput medicinal chemistry discovery and development platform that provides benefits of speed, diversity and quality which results in chemistry with better performance and small molecule development in a faster time period accomplished at a... more

Mimotopes Pty Ltd is an industry leader in the peptide and discovery chemistry sector. Mimotopes develops, markets and distributes high quality biochemical products and services for the life-science sector. Our customers range from small labs and universities worldwide, to large... more

Graffinity Technologies is the premier source for discovery of small molecular hit and lead compounds. Through our fragment based drug discovery platform we serve our partners in providing novel small molecules for drug discovery and chemical genomics approaches.

Biocortech is a biopharmaceutical company committed to the discovery and development of new treatments for psychiatric disorders, including depression, bipolar disorders, schizophrenia, and cognitive deficits. We have proprietary assays and technologies to identify biomarkers and develop... more

Magellan BioScience Group, Inc. is an innovative discovery company pursuing untapped sources of chemical diversity and identifying lead candidates derived from microorganisms for the development of new chemical entities. With more than two decades of experience, Magellan has developed... more

Macrocyclics is a research & development company actively engaged in the discovery and implementation of novel ligands and chelates for biomedical applications. Our technology platforms include high performance bifunctional ligands for diagnostic and therapeutic biotargeted... more